Summary: Owing to their functional importance, membrane proteins account for more than 50% of current drug targets. However, experimental structural data are sparse, mostly due to difficulties in their overexpression, reconstitution into membrane mimetics, and subsequent structure determination. The lack of high-resolution structures hinders drug design process and the engineering of receptors with novel function for biotechnological applications, resulting in high expectations for computational modelling tools to help fill this gap.